Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Mod Pathol

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    May 2018
  1. HUANG W, Medeiros LJ, Lin P, Wang W, et al
    MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas.
    Mod Pathol. 2018 May 21. pii: 10.1038/s41379-018-0067.
    PubMed     Text format     Abstract available


  2. HYEON J, Lee B, Shin SH, Yoo HY, et al
    Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
    Mod Pathol. 2018 May 15. pii: 10.1038/s41379-018-0064.
    PubMed     Text format     Abstract available


    February 2018
  3. KHANLARI M, Ramos JC, Sanchez SP, Cho-Vega JH, et al
    Adult T-cell leukemia/lymphoma can be indistinguishable from other more common T-cell lymphomas. The University of Miami experience with a large cohort of cases.
    Mod Pathol. 2018 Feb 15. pii: 10.1038/s41379-018-0037.
    PubMed     Text format     Abstract available


    January 2018
  4. RYMKIEWICZ G, Grygalewicz B, Chechlinska M, Blachnio K, et al
    A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Mod Pathol. 2018 Jan 12. pii: modpathol2017186. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


    October 2017
  5. MUTZBAUER G, Maurus K, Buszello C, Pischimarov J, et al
    SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma.
    Mod Pathol. 2017 Oct 20. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


  6. MIYAOKA M, Kikuti YY, Carreras J, Ikoma H, et al
    Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
    Mod Pathol. 2017 Oct 6. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


  7. HU Z, Sun Y, Schlette EJ, Tang G, et al
    CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.
    Mod Pathol. 2017 Oct 6. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


    August 2017
  8. QUESADA AE, Medeiros LJ, Desai PA, Lin P, et al
    Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
    Mod Pathol. 2017 Aug 4. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


    May 2017
  9. GAO J, Behdad A, Ji P, Wolniak KL, et al
    EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
    Mod Pathol. 2017 May 26. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


  10. GUITART J, Martinez-Escala ME, Subtil A, Duvic M, et al
    Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.
    Mod Pathol. 2017;30:761-772.
    PubMed     Text format     Abstract available


    March 2017
  11. CAI Q, Tu M, Xu-Monette ZY, Sun R, et al
    NF-kappaB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.
    Mod Pathol. 2017 Mar 10. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


    January 2017
  12. GONZALEZ-FARRE B, Martinez D, Lopez-Guerra M, Xipell M, et al
    HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  13. PINA-OVIEDO S, Medeiros LJ, Li S, Khoury JD, et al
    Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.
    Mod Pathol. 2017 Jan 13. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  14. MORSCIO J, Finalet Ferreiro J, Vander Borght S, Bittoun E, et al
    Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma.
    Mod Pathol. 2017 Jan 6. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    December 2016
  15. MACKRIDES N, Campuzano-Zuluaga G, Maque-Acosta Y, Moul A, et al
    Epstein-Barr virus-positive follicular lymphoma.
    Mod Pathol. 2016 Dec 16. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    October 2016
  16. WANG XJ, Jeffrey Medeiros L, Bueso-Ramos CE, Tang G, et al
    P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.
    Mod Pathol. 2016 Oct 14. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    September 2016
  17. SON SM, Ha SY, Yoo HY, Oh D, et al
    Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.
    Mod Pathol. 2016 Sep 30. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  18. MONTES-MORENO S, Martinez-Magunacelaya N, Zecchini-Barrese T, Gonzalez de Villambrosia S, et al
    Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.
    Mod Pathol. 2016 Sep 30. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    July 2016
  19. CHOE JY, Park M, Yun JY, Na HY, et al
    PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma.
    Mod Pathol. 2016 Jul 29. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  20. SUN R, Medeiros LJ, Young KH
    Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.
    Mod Pathol. 2016 Jul 1. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    June 2016
  21. OZAWA MG, Bhaduri A, Chisholm KM, Baker SA, et al
    A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.
    Mod Pathol. 2016 Jun 24. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


  22. ALIKHAN M, Song JY, Sohani AR, Moroch J, et al
    Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3-/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
    Mod Pathol. 2016 Jun 17. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    April 2016
  23. VALERA A, Epistolio S, Colomo L, Riva A, et al
    Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.
    Mod Pathol. 2016 Apr 29. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    March 2016
  24. SIDDIQI IN, Friedman J, Barry-Holson KQ, Ma C, et al
    Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
    Mod Pathol. 2016 Mar 11. doi: 10.1038/modpathol.2016.
    PubMed     Text format     Abstract available


    April 2015
  25. MAHMOUD AZ, George TI, Czuchlewski DR, Zhang QY, et al
    Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists.
    Mod Pathol. 2015;28:545-51.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: